Two newly approved medications expand options beyond lifestyle modifications for metabolic dysfunction-associated steatotic ...

In 2024 Stephen Rich and his colleagues published a study in which they assessed the genetic risk of developing type 1 ...

Genetic screening can mean that people at risk of type 1 diabetes get earlier treatment and better outcomes This article is ...

"As of now, semaglutide is FDA-indicated for slowing chronic kidney disease progression, [but] our results suggest that ...

Doctors and life-science companies are looking for alternative approaches to the treatment of type 1 diabetes (T1D) ...

Abu Dhabi is pioneering AI-driven healthcare, launching initiatives like the Next-Gen Wellness program to predict and prevent ...

Novo Nordisk acquires Akero Therapeutics to enhance its portfolio with efruxifermin, a promising treatment for metabolic ...

Learn about the current medication options for managing type 2 diabetes and chronic kidney disease, including SGLT2 ...

Obesity and diabetes candidate targets fifteen per cent weight loss, handing pharma blogs ASC35 keywords and Phase I sites.

New guidance from the European Association for the Study of Obesity says that semaglutide or tirzepatide should be first-line ...

Timing is everything for many things in life — including when to take medication like metformin, sold under the brand names ...

For many parents in the Capital Region, Children’s National Hospital is not just a local institution — it’s now reaffirmed as ...